PURPOSE: GF120918 has a high inhibitory effect on P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). We developed [(11)C]GF120918 as a positron emission tomography (PET) probe to assess if dual modulation of P-gp and BCRP is useful to evaluate brain penetration. PROCEDURES: PET studies using [(11)C]GF120918 were conducted on P-gp and/or Bcrp knockout mice as well as wild-type mice. RESULTS: In PET studies, the AUC(brain) ([0-60 min]) and K (1) value in P-gp/Bcrp knockout mice were nine- and 26-fold higher than that in wild-type mice, respectively. These results suggest that brain penetration of [(11)C]GF120918 is related to modulation of P-gp and BCRP and is limited by two transporters working together. CONCLUSIONS: PET using [(11)C]GF120918 may be useful for evaluating the function of P-gp and BCRP. PET using P-gp/Bcrp knockout mice may be an effective method to understand the overall contributions the functions of P-gp and BCRP.
PURPOSE: GF120918 has a high inhibitory effect on P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). We developed [(11)C]GF120918 as a positron emission tomography (PET) probe to assess if dual modulation of P-gp and BCRP is useful to evaluate brain penetration. PROCEDURES: PET studies using [(11)C]GF120918 were conducted on P-gp and/or Bcrp knockout mice as well as wild-type mice. RESULTS: In PET studies, the AUC(brain) ([0-60 min]) and K (1) value in P-gp/Bcrp knockout mice were nine- and 26-fold higher than that in wild-type mice, respectively. These results suggest that brain penetration of [(11)C]GF120918 is related to modulation of P-gp and BCRP and is limited by two transporters working together. CONCLUSIONS: PET using [(11)C]GF120918 may be useful for evaluating the function of P-gp and BCRP. PET using P-gp/Bcrp knockout mice may be an effective method to understand the overall contributions the functions of P-gp and BCRP.
Authors: John D Allen; Arnold van Loevezijn; Jeany M Lakhai; Martin van der Valk; Olaf van Tellingen; Glen Reid; Jan H M Schellens; Gerrit-Jan Koomen; Alfred H Schinkel Journal: Mol Cancer Ther Date: 2002-04 Impact factor: 6.261
Authors: Nienke A de Vries; Jin Zhao; Emily Kroon; Tessa Buckle; Jos H Beijnen; Olaf van Tellingen Journal: Clin Cancer Res Date: 2007-11-01 Impact factor: 12.531
Authors: Gert Luurtsema; Robert C Schuit; Rob P Klok; Joost Verbeek; Josée E Leysen; Adriaan A Lammertsma; Albert D Windhorst Journal: Nucl Med Biol Date: 2009-08 Impact factor: 2.408
Authors: Thomas Wanek; Claudia Kuntner; Jens P Bankstahl; Marion Bankstahl; Johann Stanek; Michael Sauberer; Severin Mairinger; Sabine Strommer; Volker Wacheck; Wolfgang Löscher; Thomas Erker; Markus Müller; Oliver Langer Journal: Eur J Nucl Med Mol Imaging Date: 2011-10-08 Impact factor: 9.236
Authors: Michael R Jablonski; Shashirekha S Markandaiah; Dena Jacob; Ni J Meng; Ke Li; Victoria Gennaro; Angelo C Lepore; Davide Trotti; Piera Pasinelli Journal: Ann Clin Transl Neurol Date: 2014-11-21 Impact factor: 4.511
Authors: Severin Mairinger; Thomas Wanek; Claudia Kuntner; Yaprak Doenmez; Sabine Strommer; Johann Stanek; Elena Capparelli; Peter Chiba; Markus Müller; Nicola A Colabufo; Oliver Langer Journal: Nucl Med Biol Date: 2012-09-13 Impact factor: 2.408